BDP/FF/GB single-inhaler triple therapy in COPD: real-world effectiveness, safety, and adherence in a pooled analysis of 5,000 patients. (PubMed, Respir Med) - Mar 3, 2026 - "Extrafine BDP/FF/GB SITT demonstrated significant real-world safety and effectiveness in improving symptoms, lung function, and adherence."
Journal • Real-world evidence • Retrospective data • Chronic Obstructive Pulmonary Disease • Immunology • Pulmonary Disease • Respiratory Diseases
|
|
Alessio Piraino; Daiana Stolz; Elena Nudo; Guy Brusselle; Laura Franzini; Luca Di Palma; Paola Rogliani; Petros Bakakos
|